A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The study aims to evaluate the efficacy and safety of belantamab mafodotin in combination with cyclophosphamide, bortezomib, and dexamethasone in adult participants with newly diagnosed (ND) AL amyloidosis .
Epistemonikos ID: 9462b59c92d462ac94de5cbb5fef89050f28d6dd
First added on: Nov 06, 2025